Skip to main content
Viewing from:
Department GEZ-LTA Erasmushogeschool
Intended for healthcare professionals
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via ACP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
For authors
About
Topic collections
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
For authors
About
Topic collections
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via ACP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are viewing from:
Department GEZ-LTA Erasmushogeschool
You are here
Home
Archive
Volume 73, Issue 7
PRDX3 is associated with metastasis and poor survival in uveal melanoma
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Original research
PRDX3 is associated with metastasis and poor survival in uveal melanoma
Online download statistics by month:
Online download statistics by month: November 2019 to April 2025
Abstract
Full
Pdf
Nov 2019
267
6
4
Dec 2019
356
40
16
Jan 2020
150
18
5
Feb 2020
90
7
3
Mar 2020
67
2
3
Apr 2020
27
2
0
May 2020
52
6
5
Jun 2020
265
17
8
Jul 2020
301
19
16
Aug 2020
69
5
6
Sep 2020
86
13
10
Oct 2020
79
9
12
Nov 2020
45
4
3
Dec 2020
75
6
5
Jan 2021
96
4
2
Feb 2021
76
3
2
Mar 2021
99
2
1
Apr 2021
148
4
3
May 2021
20
4
4
Jun 2021
2
1
0
Jul 2021
5
4
1
Aug 2021
5
1
0
Sep 2021
2
0
1
Oct 2021
84
2
1
Nov 2021
45
5
0
Dec 2021
41
3
1
Jan 2022
73
2
0
Feb 2022
39
3
2
Mar 2022
71
2
0
Apr 2022
33
3
1
May 2022
83
4
2
Jun 2022
67
5
1
Jul 2022
81
9
3
Aug 2022
66
5
1
Sep 2022
86
5
0
Oct 2022
107
2
0
Nov 2022
56
5
1
Dec 2022
52
8
1
Jan 2023
29
3
0
Feb 2023
82
6
1
Mar 2023
101
4
0
Apr 2023
40
0
0
May 2023
35
3
0
Jun 2023
21
2
0
Jul 2023
36
2
0
Aug 2023
40
1
5
Sep 2023
38
4
1
Oct 2023
46
2
0
Nov 2023
53
6
2
Dec 2023
109
7
3
Jan 2024
116
2
1
Feb 2024
45
3
3
Mar 2024
59
6
2
Apr 2024
55
1
1
May 2024
34
1
1
Jun 2024
45
2
1
Jul 2024
53
2
1
Aug 2024
43
1
0
Sep 2024
49
3
4
Oct 2024
85
2
2
Nov 2024
49
1
0
Dec 2024
50
5
1
Jan 2025
59
6
6
Feb 2025
33
1
0
Mar 2025
15
5
0
Apr 2025
9
4
1
Total
4795
325
160
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via ACP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?